• Featured Product
  • KD/KO Validated

CHRNA9 Polyclonal antibody

CHRNA9 Polyclonal Antibody for IHC, WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse

Applications

WB, IHC, FC, ELISA

Conjugate

Unconjugated

Cat no : 26025-1-AP

Synonyms

CHRNA9, HSA243342, NACHR alpha 9, NACHRA9



Tested Applications

Positive WB detected inmouse skin tissue
Positive IHC detected inhuman skin tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

The immunogen of 26025-1-AP is CHRNA9 Fusion Protein expressed in E. coli.

Tested Reactivity human, mouse
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen CHRNA9 fusion protein Ag23272
Full Name cholinergic receptor, nicotinic, alpha 9
Calculated Molecular Weight 479 aa, 55 kDa
Observed Molecular Weight 50-55 kDa
GenBank Accession NumberBC113549
Gene Symbol CHRNA9
Gene ID (NCBI) 55584
RRIDAB_2880341
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for CHRNA9 antibody 26025-1-APDownload protocol
IHC protocol for CHRNA9 antibody 26025-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanFC

Mar Drugs

Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA.

Authors - Zhihua Sun
humanWB

Mar Drugs

αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors.

Authors - Zhihua Sun
  • KO Validated